Vascular effects of a hypertensive disorder of pregnancy antepartum and postpartum: The EPOCH study.

COI Statement

Declaration of competing interest Dr. Melbye is a co-founder of Mirvie, Inc. Drs Shaw and Stevenson are co-inventors on a patent application submitted by the Chan Zuckerberg Biohub and Stanford University that covers noninvasive early prediction of preeclampsia and monitoring maternal organ health over pregnancy (US Patent and Trademark Office application numbers 63/159,400, filed on March 10, 2021, and 63/276,467, filed on November 5, 2021). The remaining authors have no relationships with industry relevant to this manuscript.